mtex-20220630
MANNATECH, INCORPORATED000105635812/31Non-accelerated FilerTRUEFALSE10-Q6/30/20222022Q2FALSE1,912,423FALSETRUEFALSE9949870.010.011,000,0001,000,0000.00010.000199,000,00099,000,0002,742,8572,742,8571,921,2621,940,687821,595802,170P3M0.21.41.01.90.20.30.24.31.940.1P2YP3YP10YP5YSUBSEQUENT EVENTSOn April 10, 2020, the Company received loan proceeds of $2,243,687 (the “Loan”) under the Paycheck Protection Program (“PPP”). The PPP was established under the recent CARES Act and is administered by the U.S. Small Business Administration. The Loan to the Company was made through JPMorgan Chase Bank, N. A., the Company’s existing banker (the “Lender”). At the time the Company applied for and received the Loan, the Company planned to use the Loan proceeds for covered payroll costs, rent and utilities in accordance with the relevant terms and conditions of the CARES Act. After the Company received the proceeds of the Loan, the SBA provided subsequent guidance interpreting the PPP. Based on such subsequent guidance, the Company made the determination to repay the Loan in full, which it did on April 30, 2020.2,243,68719.528.923.328.841.862.049.761.56.19.17.89.767.480.863.876.33.14.10.50.467.480.800010563582022-01-012022-06-3000010563582022-07-31xbrli:shares00010563582022-06-30iso4217:USD00010563582021-12-31iso4217:USDxbrli:shares00010563582022-04-012022-06-3000010563582021-04-012021-06-3000010563582021-01-012021-06-300001056358us-gaap:CommonStockMember2021-12-310001056358us-gaap:AdditionalPaidInCapitalMember2021-12-310001056358us-gaap:RetainedEarningsMember2021-12-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001056358us-gaap:TreasuryStockMember2021-12-310001056358us-gaap:RetainedEarningsMember2022-01-012022-03-3100010563582022-01-012022-03-310001056358us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001056358us-gaap:TreasuryStockMember2022-01-012022-03-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001056358us-gaap:CommonStockMember2022-03-310001056358us-gaap:AdditionalPaidInCapitalMember2022-03-310001056358us-gaap:RetainedEarningsMember2022-03-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001056358us-gaap:TreasuryStockMember2022-03-3100010563582022-03-310001056358us-gaap:RetainedEarningsMember2022-04-012022-06-300001056358us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001056358us-gaap:TreasuryStockMember2022-04-012022-06-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001056358us-gaap:CommonStockMember2022-06-300001056358us-gaap:AdditionalPaidInCapitalMember2022-06-300001056358us-gaap:RetainedEarningsMember2022-06-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001056358us-gaap:TreasuryStockMember2022-06-300001056358us-gaap:CommonStockMember2020-12-310001056358us-gaap:AdditionalPaidInCapitalMember2020-12-310001056358us-gaap:RetainedEarningsMember2020-12-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001056358us-gaap:TreasuryStockMember2020-12-3100010563582020-12-310001056358us-gaap:RetainedEarningsMember2021-01-012021-03-3100010563582021-01-012021-03-310001056358us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001056358us-gaap:TreasuryStockMember2021-01-012021-03-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001056358us-gaap:CommonStockMember2021-03-310001056358us-gaap:AdditionalPaidInCapitalMember2021-03-310001056358us-gaap:RetainedEarningsMember2021-03-310001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001056358us-gaap:TreasuryStockMember2021-03-3100010563582021-03-310001056358us-gaap:RetainedEarningsMember2021-04-012021-06-300001056358us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001056358us-gaap:TreasuryStockMember2021-04-012021-06-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001056358us-gaap:CommonStockMember2021-06-300001056358us-gaap:AdditionalPaidInCapitalMember2021-06-300001056358us-gaap:RetainedEarningsMember2021-06-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001056358us-gaap:TreasuryStockMember2021-06-3000010563582021-06-30mtex:region0001056358country:KR2022-06-300001056358country:KR2021-12-310001056358us-gaap:OtherAssetsMember2022-06-300001056358us-gaap:OtherAssetsMember2021-12-310001056358mtex:AccruedExpensesMember2022-06-300001056358mtex:AccruedExpensesMember2021-12-310001056358mtex:OtherlongtermliabilitiesMember2022-06-300001056358mtex:OtherlongtermliabilitiesMember2021-12-310001056358mtex:SoftwareToolsMember2022-06-300001056358mtex:AssociateFeesMember2022-06-30xbrli:pure0001056358us-gaap:SalesReturnsAndAllowancesMember2020-12-310001056358us-gaap:SalesReturnsAndAllowancesMember2021-01-012021-12-310001056358us-gaap:SalesReturnsAndAllowancesMember2021-12-310001056358us-gaap:SalesReturnsAndAllowancesMember2022-01-012022-06-300001056358us-gaap:SalesReturnsAndAllowancesMember2022-06-3000010563582017-04-170001056358srt:MinimumMember2022-01-012022-06-300001056358srt:MaximumMember2022-01-012022-06-300001056358us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001056358mtex:IncentiveStockOptionsMember2022-01-012022-06-300001056358us-gaap:EmployeeStockOptionMembermtex:A2017PlanMember2022-04-012022-06-300001056358us-gaap:EmployeeStockOptionMembermtex:A2017PlanMember2021-04-012021-06-300001056358us-gaap:EmployeeStockOptionMembermtex:A2017PlanMember2022-01-012022-06-300001056358us-gaap:EmployeeStockOptionMembermtex:A2017PlanMember2021-01-012021-06-300001056358us-gaap:EmployeeStockOptionMembermtex:A2017PlanMember2022-06-300001056358us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001056358us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001056358us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-06-300001056358us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-06-300001056358us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001056358us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300001056358us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-3000010563582022-03-042022-03-0400010563582022-03-162022-03-1600010563582022-06-032022-06-0300010563582022-06-152022-06-150001056358mtex:PropertyandEquipmentnetMember2022-06-300001056358mtex:PropertyandEquipmentnetMember2021-12-310001056358mtex:CurrentportionofcapitalleasesMember2022-06-300001056358mtex:CurrentportionofcapitalleasesMember2021-12-310001056358us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300001056358us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001056358us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001056358us-gaap:FairValueMeasurementsRecurringMember2022-06-300001056358us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001056358us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001056358us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001056358us-gaap:FairValueMeasurementsRecurringMember2021-12-31mtex:country0001056358srt:AmericasMember2022-04-012022-06-300001056358srt:AmericasMember2021-04-012021-06-300001056358srt:AmericasMember2022-01-012022-06-300001056358srt:AmericasMember2021-01-012021-06-300001056358srt:AsiaPacificMember2022-04-012022-06-300001056358srt:AsiaPacificMember2021-04-012021-06-300001056358srt:AsiaPacificMember2022-01-012022-06-300001056358srt:AsiaPacificMember2021-01-012021-06-300001056358us-gaap:EMEAMember2022-04-012022-06-300001056358us-gaap:EMEAMember2021-04-012021-06-300001056358us-gaap:EMEAMember2022-01-012022-06-300001056358us-gaap:EMEAMember2021-01-012021-06-300001056358mtex:ConsolidatedProductSalesMember2022-04-012022-06-300001056358mtex:ConsolidatedProductSalesMember2021-04-012021-06-300001056358mtex:ConsolidatedProductSalesMember2022-01-012022-06-300001056358mtex:ConsolidatedProductSalesMember2021-01-012021-06-300001056358mtex:ConsolidatedPackSalesMember2022-04-012022-06-300001056358mtex:ConsolidatedPackSalesMember2021-04-012021-06-300001056358mtex:ConsolidatedPackSalesMember2022-01-012022-06-300001056358mtex:ConsolidatedPackSalesMember2021-01-012021-06-300001056358mtex:ConsolidatedOtherIncludingFreightMember2022-04-012022-06-300001056358mtex:ConsolidatedOtherIncludingFreightMember2021-04-012021-06-300001056358mtex:ConsolidatedOtherIncludingFreightMember2022-01-012022-06-300001056358mtex:ConsolidatedOtherIncludingFreightMember2021-01-012021-06-300001056358srt:AmericasMembersrt:ReportableGeographicalComponentsMember2022-06-300001056358srt:AmericasMembersrt:ReportableGeographicalComponentsMember2021-12-310001056358srt:AsiaPacificMembersrt:ReportableGeographicalComponentsMember2022-06-300001056358srt:AsiaPacificMembersrt:ReportableGeographicalComponentsMember2021-12-310001056358us-gaap:EMEAMembersrt:ReportableGeographicalComponentsMember2022-06-300001056358us-gaap:EMEAMembersrt:ReportableGeographicalComponentsMember2021-12-3100010563582022-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
x    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: June 30, 2022
OR
¨    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ to ___________.
Commission File No. 000-24657
MANNATECH, INCORPORATED
(Exact Name of Registrant as Specified in its Charter)
Texas 75-2508900
(State or other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.)
1410 Lakeside Parkway, Suite 200,
Flower Mound,Texas 75028
(Address of Principal Executive Offices) (Zip Code)
Registrant’s Telephone Number, including Area Code: (972) 471-7400
                Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareMTEXThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “accelerated filer”, “large accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 ¨
Accelerated filer
 ¨
Non-accelerated filerxSmaller reporting companyxEmerging Growth Company
 ¨

If an emerging growth company, indicated by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes  o No x 

As of July 31, 2022, the number of shares outstanding of the registrant’s sole class of common stock, par value $0.0001 per share, was 1,912,423.



MANNATECH, INCORPORATED
TABLE OF CONTENTS
Part I – FINANCIAL INFORMATION 
  
  
  
  
Part II – OTHER INFORMATION 
  
  
  
  
  
  
  


Table of Contents
Special Note Regarding Forward-Looking Statements

Certain disclosures and analyses in this Form 10-Q, including information incorporated by reference, may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995 that are subject to various risks and uncertainties. Opinions, forecasts, projections, guidance, or other statements other than statements of historical fact are considered forward-looking statements and reflect only current views about future events and financial performance. Some of these forward-looking statements include statements regarding:
management’s plans and objectives for future operations;
existing cash flows being adequate to fund future operational needs;
future plans related to budgets, future capital requirements, market share growth, and anticipated capital projects and obligations;
the realization of net deferred tax assets;
the ability to curtail operating expenditures;
global statutory tax rates remaining unchanged;
the impact of future market changes due to exposure to foreign currency translations;
the possibility of certain policies, procedures, and internal processes minimizing exposure to market risk;
the impact of new accounting pronouncements on financial condition, results of operations, or cash flows;
the outcome of new or existing litigation matters;
the outcome of new or existing regulatory inquiries or investigations; and
other assumptions described in this report underlying such forward-looking statements.

Although we believe that the expectations included in these forward-looking statements are reasonable, these forward-looking statements are subject to certain events, risks, assumptions, and uncertainties, including those discussed below, the “Risk Factors” section in Part I, Item 1A of our Form 10-K for the year ended December 31, 2021, and elsewhere in this Form 10-Q and the documents incorporated by reference herein. If one or more of these risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results and developments could materially differ from those expressed in or implied by such forward-looking statements. For example, any of the following factors could cause actual results to vary materially from our projections:
the impact of the outbreak of the novel coronavirus ("COVID-19") pandemic, the availability and effectiveness of vaccines on a widespread basis and the impact of any mutations of the virus;
the current conflict between Russia and Ukraine, which could adversely affect our business in certain regions;
the impact of inflation;
disruptions in the supply chain;
overall growth or lack of growth in the nutritional supplements industry;
plans for expected future product development;
changes in manufacturing costs;
shifts in the mix of packs and products;
the future impact of any changes to global associate career and compensation plans or incentives or the regulations governing such plans and incentives;
the ability to attract and retain independent associates and preferred customers;
new regulatory changes that may affect operations, products or compensation plans or incentives;
the competitive nature of our business with respect to products and pricing;
publicity related to our products or network-marketing;
comprehensive regulation of our business model and uncertainties relating to the interpretation and enforcement of applicable laws and regulations governing direct selling and multi-level-marketing in the United States; and
the political, social, and economic climate of the countries in which we operate.
Forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” "hopes," “potential,” and “continues” or other similar words or the negative of such terms and other comparable terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals, or targets contained herein are also considered forward-looking statements. Readers are cautioned when considering these forward-looking statements to keep in mind these risks, assumptions, and uncertainties and any other cautionary statements in this report, as all of the forward-looking statements contained herein speak only as of the date of this report.

Unless stated otherwise, all financial information throughout this report and in the Consolidated Financial Statements and related Notes include Mannatech, Incorporated and all of its subsidiaries on a consolidated basis and may be referred to herein as “Mannatech,” “the Company,” “its,” “we,” “us,” “our,” or “their.”

Our products are not intended to diagnose, cure, treat, or prevent any disease, and any statements about our products contained in this report have not been evaluated by the Food and Drug Administration, also referred to herein as the “FDA”.
1

Table of Contents
 PART I – FINANCIAL INFORMATION

Item 1. Financial Statements
MANNATECH, INCORPORATED AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
ASSETSJune 30, 2022 (unaudited)December 31, 2021
Cash and cash equivalents$20,572 $24,185 
Restricted cash944 944 
Accounts receivable, net of allowance of $994 and $987 in 2022 and 2021, respectively
211 90 
Income tax receivable389 342 
Inventories, net13,884 12,020 
Prepaid expenses and other current assets2,745 2,888 
Deferred commissions3,214 2,369 
Total current assets41,959 42,838 
Property and equipment, net2,309 2,882 
Construction in progress1,833 1,357 
Long-term restricted cash470 503 
Other assets9,317 9,220 
Deferred tax assets, net2,793 2,825 
Total assets$58,681 $59,625 
LIABILITIES AND SHAREHOLDERS’ EQUITY  
Current portion of finance leases$56 $68 
Accounts payable5,137 3,969 
Accrued expenses9,891 9,224 
Commissions and incentives payable9,019 9,611 
Taxes payable1,535 2,154 
Current notes payable428 205 
Deferred revenue5,992 4,867 
Total current liabilities32,058 30,098 
Finance leases, excluding current portion57 66 
Other long-term liabilities5,288 5,049 
Total liabilities37,403 35,213 
Commitments and contingencies
Shareholders’ equity:  
Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding  
Common stock, $0.0001 par value, 99,000,000 shares authorized, 2,742,857 shares issued and 1,921,262 shares outstanding as of June 30, 2022 and 2,742,857 shares issued and 1,940,687 shares outstanding as of December 31, 2021  
Additional paid-in capital33,407 33,277 
Retained earnings7,756 7,708 
Accumulated other comprehensive income(492)2,342 
Treasury stock, at average cost, 821,595 shares as of June 30, 2022 and 802,170 shares as of December 31, 2021(19,393)(18,915)
Total shareholders’ equity21,278 24,412 
Total liabilities and shareholders’ equity$58,681 $59,625 

See accompanying notes to unaudited consolidated financial statements.
2

Table of Contents
MANNATECH, INCORPORATED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS – (UNAUDITED)
(in thousands, except per share information)
 Three Months Ended
June 30,
Six Months Ended
June 30,
 2022202120222021
Net sales$34,976 $42,504 $67,360 $80,823 
Cost of sales7,920 10,126 15,011 17,348 
Gross profit27,056 32,378 52,349 63,475 
Operating expenses:   
Commissions and incentives14,137 16,898 27,245 32,496 
Selling and administrative expenses6,914 7,571 13,823 14,682 
Depreciation and amortization expense301 442 633 952 
Other operating costs4,851 5,449 9,760 10,538 
Total operating expenses26,203 30,360 51,461 58,668 
Income from operations853 2,018 888 4,807 
Interest income, net23 7 38 29 
Other income (expense), net(84)152 1 (130)
Income before income taxes792 2,177 927 4,706 
Income tax provision(98)(48)(99)(383)
Net income$694 $2,129 $828 $4,323 
Earnings per common share:  
Basic$0.36 $1.03 $0.43 $2.09 
Diluted$0.34 $0.99 $0.40 $2.03 
Weighted-average common shares outstanding:  
Basic1,942 2,060 1,944 2,065 
Diluted2,031 2,139 2,052 2,128 

MANNATECH, INCORPORATED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME – (UNAUDITED)
(in thousands)
 Three Months Ended
June 30,
Six Months Ended
June 30,
 2022202120222021
Net income$694 $2,129 $828 $4,323 
Foreign currency translations(2,161)72 (2,834)(1,284)
Comprehensive (loss) income$(1,467)$2,201 $(2,006)$3,039 
 
See accompanying notes to unaudited consolidated financial statements.
3

Table of Contents
MANNATECH, INCORPORATED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(UNAUDITED)
(in thousands)
 Common stock
Par value
Additional
paid-in
capital
Retained
earnings
Accumulated
other
comprehensive
income
Treasury
stock
Total
shareholders’
equity
Balance at January 1, 2022$ $33,277 $7,708 $2,342 $(18,915)$24,412 
Net income— — 134 — — 134 
Payment of cash dividends— — (390)— — (390)
Charge related to stock-based compensation— 7 — — — 7 
Issuance of unrestricted shares— 97 — — 143 240 
Stock option exercises— (22)— 22  
Foreign currency translations— — — (673)— (673)
Balance at March 31, 2022$ $33,359 $7,452 $1,669 $(18,750)$23,730 
Net income— — 694 — — 694 
Payment of cash dividends— — (390)— — (390)
Charge related to stock-based compensation— 48 — — — 48 
Repurchase of common stock— — — — (643)(643)
Foreign currency translations— — — (2,161)— (2,161)
Balance at June 30, 2022$ $33,407 $7,756 $(492)$(19,393)$21,278 


Common stock
Par value
Additional
paid-in
capital
Retained earningsAccumulated
other
comprehensive
income
Treasury
stock
Total
shareholders’
equity
Balance at January 1, 2021$ $33,795 $2,213 $5,150 $(15,186)$25,972 
Net income— — 2,194 — — 2,194 
Payment of cash dividends— — (333)— — (333)
Charge related to stock-based compensation— 6 — — — 6 
Issuance of unrestricted shares— (44)— — 254 210 
Repurchase of common stock— — — — (350)(350)
Foreign currency translations— — — (1,356)— (1,356)
Balance at March 31, 2021$ $33,757 $4,074 $3,794 $(15,282)$26,343 
Net income— — 2,129 — — 2,129 
Payment of cash dividends— — (330)— — (330)
Charge related to stock-based compensation— 29 — — — 29 
Stock option exercises— (28)— — 28  
Repurchase of common stock— — — — (4,511)(4,511)
Foreign currency translations— — — 72 — 72 
Balance at June 30, 2021$ $33,758 $5,873 $3,866 $(19,765)$23,732 

See accompanying notes to unaudited consolidated financial statements.
4

Table of Contents
MANNATECH, INCORPORATED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS – (UNAUDITED)
(in thousands)
 Six Months Ended
June 30,
 20222021
CASH FLOWS FROM OPERATING ACTIVITIES:  
Net income$828 $4,323 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization633 952 
Non-cash operating lease expense1,051 853 
Provision for inventory losses225 316 
Provision for doubtful accounts(29)256 
Loss on disposal of assets 37 
Charge related to stock-based compensation295 245 
Deferred income taxes32 104 
Changes in operating assets and liabilities:  
Accounts receivable(92)(301)
Income tax receivable(47)581 
Inventories(2,089)(981)
Prepaid expenses and other current assets671 263 
Deferred commissions(845)5 
Other assets230 658 
Accounts payable1,168 312 
Accrued expenses(711)(40)
Other liabilities239 (1,156)
Taxes payable(619)631 
Commissions and incentives payable(592)659 
Deferred revenue1,125 608 
Net cash provided by operating activities1,473 8,325 
CASH FLOWS FROM INVESTING ACTIVITIES:  
Acquisition of property and equipment(536)(268)
CASH FLOWS FROM FINANCING ACTIVITIES:  
Repurchase of common stock(643)(4,861)
Payment of cash dividends(780)(663)
Repayment of notes payable and finance lease liabilities(345)(669)
Net cash used in financing activities(1,768)(6,193)
Effect of currency exchange rate changes on cash and cash equivalents(2,815)(1,271)
Net (decrease) increase in cash, cash equivalents, and restricted cash(3,646)593 
Cash, cash equivalents, and restricted cash at the beginning of the period25,632 27,497 
Cash, cash equivalents, and restricted cash at the end of the period$21,986 $28,090 
    

See accompanying notes to unaudited consolidated financial statements.


5

Table of Contents
Six Months Ended
June 30,
20222021
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:  
Income taxes paid$654 $80 
Interest paid on finance leases and other financing arrangements14 22 
Assets acquired through other financing arrangements528  
Operating lease right-of-use assets acquired in exchange for new operating lease liabilities1,378 73 
Finance lease right-of-use assets acquired in exchange for new finance lease liabilities19  
Treasury shares exchanged for stock options exercised22 

See accompanying notes to unaudited consolidated financial statements.



6

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS



    
NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

    Mannatech, Incorporated (together with its subsidiaries, the “Company”), located in Flower Mound, Texas, was incorporated in the state of Texas on November 4, 1993 and is listed on the Nasdaq Global Select Market under the symbol “MTEX”. The Company develops, markets, and sells high-quality, proprietary nutritional supplements, topical and skin care and anti-aging products, and weight-management products. We currently sell our products into three regions: (i) the Americas (the United States, Canada and Mexico); (ii) EMEA (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom); and (iii) Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China).

Active business building associates ("independent associates" or "associates" or "distributors") and preferred customers purchase the Company’s products at published wholesale prices. The Company cannot distinguish products sold for personal use from other sales, when sold to associates, because it is not involved with the products after delivery, other than usual and customary product warranties and returns. Only associates are eligible to earn commissions and incentives. We also ship our products to customers in the following countries: Belgium, France, Greece, Italy, Luxembourg, and Poland. The Company operates a non-direct selling business in mainland China. Our subsidiary in China, Meitai Daily Necessity & Health Products Co., Ltd. (“Meitai”), is operating as a traditional retailer under a cross-border e-commerce model in China. Meitai cannot legally conduct a direct selling business in China unless it acquires a direct selling license in China.

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with instructions for Form 10-Q and Article 8-03 of Regulation S-X. Accordingly, the Company’s consolidated financial statements and footnotes contained herein do not include all of the information and footnotes required by GAAP to be considered “complete financial statements”. However, in the opinion of the Company’s management, the accompanying unaudited consolidated financial statements and footnotes contain all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company’s consolidated financial information as of, and for, the periods presented. The Company cautions that its consolidated results of operations for an interim period are not necessarily indicative of its consolidated results of operations to be expected for its fiscal year. The December 31, 2021 consolidated balance sheet was included in the audited consolidated financial statements in the Company’s annual report on Form 10-K for the year ended December 31, 2021 and filed with the United States Securities and Exchange Commission (the “SEC”) on March 15, 2022 (the “2021 Annual Report”), which includes all disclosures required by GAAP. Therefore, these unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company included in the 2021 Annual Report.

The Company depends on an independent sales force of distributors to market and sell its products to consumers. Social distancing and shelter-in-place directives in response to the COVID-19 pandemic have impacted and may continue to impact their ability to engage with potential and existing customers. The adverse economic effects of COVID-19 may also materially decrease demand for the Company’s products based on changes in consumer behavior or the restrictions in place by governments trying to curb the outbreak. For example, the Company has rescheduled corporate sponsored events, and in some cases, our associates have canceled sales meetings.

While the conditions described above are expected to be temporary, prolonged workforce disruptions, disruption in our supply chain or potential decreases in consumer demands may negatively impact sales in fiscal year 2022 and the Company’s overall liquidity. The full impact of COVID-19 continues to evolve and we are actively monitoring the global situation with a focus on our financial condition, liquidity, operations, suppliers, industry, and workforce.

Principles of Consolidation

The consolidated financial statements and footnotes include the accounts of Mannatech and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.


7

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS


Use of Estimates

The preparation of the Company’s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company’s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. However, actual results may differ from these estimates under different assumptions or conditions.

The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered the most significant are described in this note to the consolidated financial statements, Organization and Summary of Significant Accounting Policies.

Cash, Cash Equivalents, and Restricted Cash

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash proceeds from credit card receivables are received within 24 to 72 hours. As of June 30, 2022 and December 31, 2021, credit card receivables were $2.4 million and $1.2 million, respectively. As of June 30, 2022 and December 31, 2021, cash and cash equivalents held in bank accounts in foreign countries totaled $16.0 million and $22.6 million, respectively. The Company invests cash in liquid instruments, such as money market funds and interest-bearing deposits. The Company holds cash in high quality financial institutions and does not believe it has an excessive exposure to credit concentration risk.

    A significant portion of our cash and cash equivalent balances were concentrated within the Republic of Korea, with total net assets within this foreign location totaling $20.0 million and $20.1 million at June 30, 2022 and December 31, 2021, respectively. In addition, for the three and six months ended June 30, 2022 and 2021, a concentrated portion of our operating cash flows were earned from operations within the Republic of Korea. An adverse change in economic conditions within the Republic of Korea could negatively affect the Company’s results of operations. 

The Company is required to restrict cash for: (i) direct selling insurance premiums and credit card sales in the Republic of Korea; (ii) reserve on credit card sales in the United States and Canada; and (iii) the Australia building lease collateral. At each of June 30, 2022 and December 31, 2021, our total restricted cash was $1.4 million.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Company's consolidated balance sheets to the total amount presented in the consolidated statement of cash flows (in thousands):
June 30, 2022December 31, 2021
Cash and cash equivalents at beginning of period$24,185 $22,207 
Current restricted cash at beginning of period944 944 
Long-term restricted cash at beginning of period503 4,346 
Cash, cash equivalents, and restricted cash at beginning of period$25,632 $27,497 
Cash and cash equivalents at end of period$20,572 $24,185 
Current restricted cash at end of period944 944 
Long-term restricted cash at end of period470 503 
Cash, cash equivalents, and restricted cash at end of period$21,986 $25,632 

8

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS


Accounts Receivable

Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. As of June 30, 2022 and December 31, 2021, receivables consisted primarily of amounts due from preferred customers and associates. At June 30, 2022 and December 31, 2021, the Company's accounts receivable balance (net of allowance) were $0.2 million and $0.1 million, respectively. The Company periodically evaluates its receivables for collectability based on historical experience, recent account activities, and the length of time receivables are past due and writes-off receivables when they become uncollectible. At each of June 30, 2022 and December 31, 2021, the Company held an allowance for doubtful accounts of $1.0 million.

Inventories

Inventories consist of raw materials, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or net realizable value. The Company periodically reviews inventories for obsolescence and any inventories identified as obsolete are reserved or written off.

Other Assets

As of June 30, 2022 and December 31, 2021, other assets were $9.3 million and $9.2 million, respectively. These amounts primarily consisted of right-of-use assets related to operating leases for office space and equipment, net of lease incentives, of $5.0 million and $4.6 million as of June 30, 2022 and December 31, 2021, respectively. See Note 8, Leases, for more information on these assets. Also included in Other Assets were deposits for building leases in various locations of $1.9 million at each of June 30, 2022 and December 31, 2021. Additionally, included in the June 30, 2022 and December 31, 2021 balances was $2.2 million and $2.4 million, respectively, representing a deposit with Mutual Aid Cooperative and Consumer in the Republic of Korea, an organization established by the Republic of Korea’s Fair Trade Commission to protect consumers who participate in network marketing activities. Finally, each of the June 30, 2022 and December 31, 2021 balances included $0.2 million of indefinite lived intangible assets relating to the Manapol® powder trademark.

Accrued Expenses

As of June 30, 2022 and December 31, 2021, accrued expenses were $9.9 million and $9.2 million, respectively. These amounts primarily consisted of $1.9 million and $2.4 million representing employee benefits, which included accrued wages, bonus and severance as of June 30, 2022 and December 31, 2021, respectively. Also included in the June 30, 2022 and December 31, 2021 balances were non-inventory accrued liabilities of $2.8 million and $3.4 million, respectively. Additionally, included in the June 30, 2022 and December 31, 2021 balances was $1.6 million and $1.5 million for the current portion of operating lease liabilities, respectively. At June 30, 2022 and December 31, 2021, also included in the balances were $0.9 million and $1.0 million for accrued auditing and accounting fees, respectively. At June 30, 2022 and December 31, 2021, other accrued expenses were $2.7 million and $0.9 million, respectively.

Notes Payable

Notes payable were $0.4 million and $0.2 million as of June 30, 2022 and December 31, 2021, respectively, as a result of funding from a capital financing agreement related to our investment in leasehold improvements, computer hardware and software and other financing arrangements. As of June 30, 2022 and December 31, 2021, the current portion was $0.4 million and $0.2 million, respectively.

Other Long-Term Liabilities

Other long-term liabilities were $5.3 million and $5.0 million as of June 30, 2022 and December 31, 2021, respectively. As of June 30, 2022 and December 31, 2021, the balance is primarily composed of long-term operating lease obligations of $4.6 million and $4.3 million, respectively. See Note 8, Leases, for more information. Certain operating leases for the Company’s regional office facilities contain a restoration clause that requires the Company to restore the premises to its original condition. At each of June 30, 2022 and December 31, 2021, accrued restoration costs related to these leases amounted to $0.3 million. At each of June 30, 2022 and December 31, 2021, the Company also recorded a long-term liability for estimated defined benefit obligation related to a non-U.S. defined benefit plan for its Japan operations of $0.2 million (see Note 9, Employee Benefit Plans, of the Company’s 2021 Annual Report).
9

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Revenue Recognition

The Company’s revenue is derived from sales of individual products and associate fees or, in certain geographic markets, starter packs. Substantially all of the Company’s product sales are made at published wholesale prices to associates and preferred customers. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience. The Company recognizes revenue from shipped products when control of the product transfers to the customer, thus the performance obligation is satisfied. Corporate-sponsored event revenue is recognized when the event is held.
Revenues from associate fees relate to providing associates with the right to earn commissions, benefits and incentives for an annual period. Revenue from software tools included in the first contractual year is recognized over three months and revenue from associate fees is recognized over 12 months (see Contracts with Multiple Performance Obligations for recognition guidelines). Almost all orders are paid via credit card. See Note 10, Segment Information, for disaggregation of revenues by geographic segment and type.
The Company collected associate fees within the United States, Canada, South Africa, Japan, Australia, New Zealand, Singapore, Hong Kong, Taiwan, Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, the Netherlands, Norway, Spain, Sweden and the United Kingdom.

    Contracts with Multiple Performance Obligations

Orders placed by associates or preferred customers constitute our contracts. Product sales placed in the form of an automatic order contain two performance obligations: (a) the sale of the product and (b) the loyalty program. For these contracts, the Company accounts for each of these obligations separately as they are each distinct. The transaction price is allocated between the product sale and the loyalty program on a relative standalone selling price basis. Sales placed through a one-time order contain only the first performance obligation noted above - the sale of the product.

The Company provides associates with access to a complimentary three-month package for the Success TrackerTM and Mannatech+ online business tools with the first payment of an associate fee. The first payment of an associate fee contains three performance obligations: (a) the associate fee, whereby the Company provides an associate with the right to earn commissions, bonuses and incentives for a year; (b) three months of complimentary access to utilize the Success Tracker™ online tool; and (c) three months of complimentary access to utilize the Mannatech+ online business tool. The transaction price is allocated between the three performance obligations on a relative standalone selling price basis. Associates do not have complimentary access to online business tools after the first contractual period.

With regards to both of the aforementioned contracts, the Company determines the standalone selling prices based on our overall pricing objectives, taking into consideration market conditions and other factors, including the value of the contracts.

    Deferred Commissions

The Company defers commissions on (i) the sales of products shipped but not received by customers by the end of the respective period and (ii) the loyalty program. Deferred commissions are incremental costs and are amortized to expense consistent with how the related revenue is recognized. Deferred commissions were $2.4 million for the year ended December 31, 2021. Of this balance, $1.0 million was amortized to commissions expense for the six months ended June 30, 2022. At June 30, 2022, deferred commissions were $3.2 million.

    Deferred Revenue

    The Company defers certain components of its revenue. Deferred revenue consisted of: (i) sales of products shipped but not received by customers by the end of the respective period; (ii) revenue from the loyalty program; (iii) prepaid registration fees from customers planning to attend a future corporate-sponsored event; and (iv) prepaid annual associate fees. At December 31, 2021, the Company’s deferred revenue was $4.9 million. Of this balance, $2.6 million was recognized as revenue for the six months ended June 30, 2022. At June 30, 2022, the Company’s deferred revenue was $6.0 million.

10

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

The Company’s customer loyalty program conveys a material right to the customer as it provides the promise to redeem loyalty points for the purchase of products, which is based on earning points through placing consecutive qualified orders. The Company factors in breakage rates, which is the percentage of the loyalty points that are expected to be forfeited or expire, for purposes of revenue recognition. Breakage rates are estimated based on historical data and can be reasonably and objectively determined. The deferred revenue associated with the loyalty program at each of June 30, 2022 and December 31, 2021 was $4.3 million.

Loyalty program(in thousands)
Loyalty deferred revenue as of January 1, 2021$4,487 
Loyalty points forfeited or expired(3,987)
Loyalty points used(9,809)
Loyalty points vested11,676 
Loyalty points unvested1,925 
Loyalty deferred revenue as of December 31, 2021$4,292 

Loyalty deferred revenue as of January 1, 2022$4,292 
Loyalty points forfeited or expired(1,874)
Loyalty points used(4,761)
Loyalty points vested5,681 
Loyalty points unvested972 
Loyalty deferred revenue as of June 30, 2022$4,310 

    Sales Refunds and Allowances

The Company utilizes the expected value method, as set forth by Accounting Standard Codification ("ASC") Topic 606 Revenue from Contracts with Customers ("ASC 606"), to estimate the sales returns and allowance liability by taking the weighted average of the sales return rates over a rolling six-month period. The Company allocates the total amount recorded within the sales return and allowance liability as a reduction of the overall transaction price for the Company’s product sales. The Company deems the sales refund and allowance liability to be a variable consideration.

Historically, sales returns have not materially changed through the years, as the majority of our customers who return their merchandise do so within the first 90 days after the original sale. Sales returns have historically averaged 1.5% or less of our gross sales. As of each of the periods set forth below, our sales return reserve consisted of the following (in thousands):

Sales reserve as of January 1, 2021$71 
Provision related to sales made in current period778 
Adjustment related to sales made in prior periods(11)
Actual returns or credits related to current period(728)
Actual returns or credits related to prior periods(55)
Sales reserve as of December 31, 2021$55 
Sales reserve as of January 1, 2022$55 
Provision related to sales made in current period1,017 
Adjustment related to sales made in prior periods(2)
Actual returns or credits related to current period(340)
Actual returns or credits related to prior periods(48)
Sales reserve as of June 30, 2022$682 
    

11

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Shipping and Handling Costs

The Company records inbound freight as a component of inventory and cost of sales. The Company records freight and shipping fees collected from its customers as fulfillment costs. In accordance with ASC 606-10-25-18a, freight and shipping fees are not deemed to be separate performance obligations as these activities occur before the customer receives the product.
Commissions and Incentives

Associates earn commissions and incentives based on their direct and indirect commissionable net sales over each month of the fiscal year. The Company accrues commissions and incentives when earned by associates and pays commissions on product and pack sales on a monthly cycle.

Comprehensive Income and Accumulated Other Comprehensive Income

Comprehensive income is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. The Company’s comprehensive income consists of the Company’s net income, foreign currency translation adjustments from its Japan, Republic of Korea, Taiwan, Denmark, Norway, Sweden, Mexico and China operations, remeasurement of intercompany balances classified as equity in its Korea, and Mexico operations, and changes in the pension obligation for its Japanese employees.
    Accounting Pronouncements Issued but Not Yet Effective

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). This standard adds to U.S. GAAP an impairment model (known as the current expected credit loss ("CECL") model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses, which is intended to result in the more timely recognition of losses. Under the CECL model, entities will estimate credit losses over the entire contractual term of the instrument (considering estimated prepayments, but not expected extensions or modifications) from the date of initial recognition of the financial instrument. Measurement of expected credit losses are to be based on relevant forecasts that affect collectability. The scope of financial assets within the CECL methodology is broad and includes trade receivables from certain revenue transactions and certain off-balance sheet credit exposures. Different components of the guidance require modified retrospective or prospective adoption. In November 2019, the FASB issued ASU 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) ("ASU 2019-10") which defers the effective date for smaller reporting companies by three years to December 15, 2022 for fiscal years, and interim periods within those fiscal years, beginning after that date. Accordingly, this standard will be effective for the Company as of January 1, 2023. While our review is ongoing, we believe ASU 2016-13 will only have applicability to our receivables from revenue transactions. Under ASC 606, revenue is recognized when, among other criteria, it is probable that the entity will collect the consideration to which it is entitled for goods or services transferred to a customer. At the point that trade receivables are recorded, they become subject to the CECL model and estimates of expected credit losses on trade receivables over their contractual life will be required to be recorded at inception based on historical information, current conditions, and reasonable and supportable forecasts. The Company is continuing to evaluate whether the new guidance will have an impact on our consolidated financial statements or existing internal controls.

    Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

NOTE 2: INVENTORIES

Inventories consist of raw materials, finished goods, and promotional materials. The Company provides an allowance for any slow-moving or obsolete inventories. Inventories as of June 30, 2022 and December 31, 2021, consisted of the following (in thousands):
 June 30, 2022December 31, 2021
Raw materials$3,297 $3,271 
Finished goods10,971 9,196 
Inventory reserves for obsolescence(384)(447)
Total$13,884 $12,020 
12

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS



NOTE 3: INCOME TAXES

For the three and six months ended June 30, 2022, the Company’s effective tax rate was 12.4% and 10.7%, respectively. For the three and six months ended June 30, 2021, the Company’s effective tax rate was 2.2% and 8.1%, respectively. For the three and six months ended June 30, 2022 and 2021, the Company's effective tax rate was determined based on the estimated annual effective income tax rate.

The effective tax rate for the three and six months ended June 30, 2022 was different from the federal statutory rate due to the effect of changes in valuation allowances recorded in certain jurisdictions and the foreign derived intangible deduction in the US.

The effective tax rate for the three and six months ended June 30, 2021 was different from the federal statutory rate due primarily to the mix of earnings across jurisdictions and the associated valuation allowances recorded on losses in certain jurisdictions.



13

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 4: EARNINGS PER SHARE

    The Company calculates basic Earnings per Share ("EPS") by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted EPS also reflects the potential dilution that could occur if common stock were issued for awards outstanding under the Mannatech, Incorporated 2017 Stock Incentive Plan (described below).

    In determining the potential dilutive effect of outstanding stock options for the three and six months ended June 30, 2022, the Company used the quarterly and six month ended average common stock close price of $26.94 and $31.42 per share, respectively.

For each of the three and six months ended June 30, 2022, there were 1.94 million weighted-average common shares outstanding used for the basic EPS calculation. For the three and six months ended June 30, 2022, approximately 0.09 million and 0.11 million shares, respectively, subject to options were included in the calculation resulting in 2.03 million and 2.05 million dilutive shares, respectively, used to calculate diluted EPS. For each of the three and six months ended June 30, 2022, less than 0.1 million shares were excluded from the diluted EPS calculation.

In determining the potential dilutive effect of outstanding stock options for the three and six months ended June 30, 2021, the Company used the quarterly and six month ended average common stock close price of $22.10 and $20.22 per share, respectively.

For the three and six months ended June 30, 2021, there were 2.06 million and 2.07 million weighted-average common shares outstanding used for the basic EPS calculation, respectively. For the three and six months ended June 30, 2021, approximately 0.08 million and 0.06 million shares subject to options were included in the calculation resulting in 2.14 million and 2.13 million dilutive shares used to calculate diluted EPS, respectively. For the three and six months ended June 30, 2021, less than 0.1 million and approximately 0.1 million shares, respectively, of the Company's common stock subject to options were excluded from the diluted EPS calculation as the effect would have been antidilutive.

14

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 5: STOCK-BASED COMPENSATION

The Company currently has one active stock-based compensation plan, the Mannatech, Incorporated 2017 Stock Incentive Plan, which was adopted by the Company’s Board of Directors (the "Board") on April 17, 2017 and was approved by its shareholders on June 8, 2017, and subsequently amended by the Board at its February 2019 special meeting, which amendment was approved by the Company's shareholders on June 11, 2019 (as amended, the "2017 Plan"). The 2017 Plan supersedes the Mannatech, Incorporated 2008 Stock Incentive Plan (as amended, the "2008 Plan"), which was set to expire on February 20, 2018. The Board has reserved a maximum of 370,000 shares of our common stock that may be issued under the 2017 Plan (subject to adjustments for stock splits, stock dividends or other changes in corporate capitalization). As of June 30, 2022, the Company had a total of 126,276 shares available for grant under the 2017 Plan, which expires on April 16, 2027.

The 2017 Plan provides for grants of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance stock and performance stock units to our employees, board members, and consultants. However, only employees of the Company and its corporate subsidiaries are eligible to receive incentive stock options. The exercise price per share for all stock options will be no less than the market value of a share of common stock on the date of grant. Any incentive stock option granted to an employee owning more than 10% of our common stock will have an exercise price of no less than 110% of our common stock’s market value on the grant date.

The majority of stock options vest over two or three years, and generally are granted with a term of ten years, or five years in the case of an incentive option granted to an employee who owns more than 10% of our common stock.

The Company records stock-based compensation expense related to granting stock options in selling and administrative expenses. During the six months ended June 30, 2022 and 2021, the Company granted 11,807 and 10,000 stock options, respectively. The fair value of stock options granted during the six months ended June 30, 2022 and 2021 was approximately $7.21 and $6.77 per share, respectively. The Company recognized compensation expense as follows for the three and six months ended June 30 (in thousands):

 Three Months Ended
June 30,
Six Months Ended
June 30,
 2022202120222021
Total gross compensation expense$48 $29 $56 $35 
Total tax benefit associated with compensation expense11 7 13 8 
Total net compensation expense$37 $22 $43 $27 
 
As of June 30, 2022, the Company expects to record compensation expense in the future as follows (in thousands):
Six months
ending
December 31,
2022
Years ending December 31,
 20232024
Total gross unrecognized compensation expense$23 $33 $10 
Tax benefit associated with unrecognized compensation expense6 8 2 
Total net unrecognized compensation expense$17 $25 $8 

15

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6: SHAREHOLDERS’ EQUITY

Treasury Stock

During the three months ended June 30, 2022, the Company repurchased 31,411 shares of its outstanding common stock. During the three months ended June 30, 2021, the Company repurchased 171,709 additional shares of its outstanding common stock, which included 171,433 shares of its outstanding common stock repurchased pursuant to the tender offer.

As of June 30, 2022, the Company had 1,921,262 shares of common stock outstanding. As of June 30, 2021, the Company had 1,892,646 shares of common stock outstanding.

Accumulated Other Comprehensive Income

Accumulated other comprehensive income, reflected in the Consolidated Statement of Shareholders’ Equity, represents net income plus the results of certain shareholders’ equity changes not reflected in the Consolidated Statements of Operations, such as foreign currency translation and certain pension and post-retirement benefit obligations. The after-tax components of accumulated other comprehensive income, are as follows (in thousands):
 Foreign
Currency
Translation
Pension
Postretirement
Benefit
Obligation
Accumulated
Other
Comprehensive
Income, Net
Balance as of December 31, 2021$1,961 $381 $2,342 
Current-period change (1)
(2,834) (2,834)
Balance as of June 30, 2022$(873)$381 $(492)

(1) No material amounts reclassified from accumulated other comprehensive income.

Dividends

On March 4, 2022, the Board declared a dividend of $0.20 per share that was paid on March 30, 2022 to shareholders of record on March 16, 2022, for an aggregate amount of $0.4 million.

On June 3, 2022, the Board declared a dividend of $0.20 per share that was paid on June 29, 2022 to shareholders of record on June 15, 2022, for an aggregate amount of $0.4 million.



NOTE 7: LITIGATION

Litigation in General

The Company has incurred several claims in the normal course of business. The Company believes such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows.

The Company maintains certain liability insurance; however, certain costs of defending lawsuits are not covered by or only partially covered by its insurance policies, including claims that are below insurance deductibles. Additionally, insurance carriers could refuse to cover certain claims, in whole or in part. The Company accrues costs to defend itself from litigation as they are incurred.

The outcome of litigation is uncertain, and despite management’s views of the merits of any litigation, or the reasonableness of the Company’s estimates and reserves, the Company’s financial statements could nonetheless be materially affected by an adverse judgment. The Company believes it has adequately reserved for the contingencies arising from current legal matters where an outcome was deemed to be probable, and the loss amount could be reasonably estimated. No legal reserve was deemed necessary at June 30, 2022.

16

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 8: LEASES

The Company has entered into contractual lease arrangements to rent office space and equipment from third-party lessors. See Note 5 to the consolidated financial statements in our 2021 Annual Report.

    As of June 30, 2022, the Company had net operating lease right-of-use (“ROU”) assets of $5.0 million and net finance lease right-of-use assets of $0.2 million. At June 30, 2022, our operating lease liabilities were $6.2 million and our finance lease liabilities were $0.1 million.

The weighted-average remaining lease term and discount rate related to the Company’s operating lease liabilities as of June 30, 2022 were 4.25 years and 4.0%, respectively. The weighted-average remaining lease term and discount rate related to the Company’s finance lease liabilities as of June 30, 2022 were 2.45 years and 5.2%, respectively. The Company's uses the discount rates implicit in each lease, or an estimate of the Company's incremental borrowing rate if the rate implicit in a lease cannot be readily determined.

    As of June 30, 2022 and December 31, 2021 our leased assets and liabilities consisted of the following (in thousands):
LeasesClassificationJune 30, 2022December 31, 2021
Right-of-use assets
    Operating leasesOther assets$4,972 $4,625 
    Finance leasesProperty and equipment, net154 180 
Total right-of-use assets$5,126 $4,805 
Current portion of lease liabilities
    Operating leasesAccrued expenses$1,612 $1,493 
    Finance leasesCurrent portion of finance leases56 68 
Long-term portion of lease liabilities
    Operating leasesOther long-term liabilities4,558 4,318 
    Finance leasesFinance leases, excluding current portion57 66 
Total lease liabilities$6,283 $5,945 

As of June 30, 2022 the Company's minimum future lease payments on operating and financing leases were as follows (in thousands):
June 30, 2022
Maturity of lease liabilitiesOperating LeasesFinancing Leases
Remaining 2022$1,045 $33 
20231,650 52 
20241,523 26 
2025994 6 
2026701 5 
Thereafter918 1 
Total minimum lease payments$6,831 $123 
Imputed interest(661)(10)
Present value of minimum lease payments$6,170 $113 
    
17

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 9: FAIR VALUE

The Company utilizes fair value measurements to record fair value adjustments to certain financial assets and to determine fair value disclosures.

Fair Value Measurements and Disclosure (Topic 820) of the FASB establishes a fair value hierarchy that requires the use of observable market data, when available, and prioritizes the inputs to valuation techniques used to measure fair value in the following categories:
Level 1 – Quoted unadjusted prices for identical instruments in active markets.
Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which all observable inputs and significant value drivers are observable in active markets.
Level 3 – Model-derived valuations in which one or more significant inputs or significant value drivers are unobservable, including assumptions developed by the Company.
The primary objective of the Company’s investment activities is to preserve principal while maximizing yields without significantly increasing risk. The investment instruments held by the Company are money market funds and interest-bearing deposits for which quoted market prices are readily available. The Company considers these highly liquid investments to be cash equivalents. These investments are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company does not have any material financial liabilities that were required to be measured at fair value on a recurring basis at June 30, 2022.

The table below presents the recorded amount of financial assets measured at fair value (in thousands) on a recurring basis as of June 30, 2022 and December 31, 2021.
June 30, 2022Level 1Level 2Level 3Total
Assets    
Money Market Funds – JPMorgan Chase, US$450 $ $ $450 
Interest bearing deposits – various banks5,121   5,121 
Total assets$5,571 $ $ $5,571 
Amounts included in:    
Cash and cash equivalents$4,728 $ $ $4,728 
Restricted cash680   680 
Long-term restricted cash163   163 
Total$5,571 $ $ $5,571 

December 31, 2021Level 1Level 2Level 3Total
Assets    
Interest bearing deposits – various banks7,838   7,838 
Total assets$7,838 $ $ $7,838 
Amounts included in:    
Cash and cash equivalents$6,986 $ $ $6,986 
Restricted cash680   680 
Long-term restricted cash172   172 
Total$7,838 $ $ $7,838 

18

MANNATECH, INCORPORATED AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 10: SEGMENT INFORMATION

The Company's sole reporting segment is one where we sell proprietary nutritional supplements, skin care and anti-aging products, and weight-management and fitness products through network marketing distribution channels operating in twenty-four countries. Each of the business units receives associate fees or sells similar packs (in the case of Mexico and South Korea, where packs have not been replaced with associate fees, see Note 1, Organization and Summary of Significant Accounting Policies) and possesses similar economic characteristics, such as selling prices and gross margins. In each country, the Company markets its products and pays commissions and incentives in similar market environments. The Company’s management reviews its financial information by country and focuses its internal reporting and analysis of revenues by pack sales, associate fees and product sales. The Company sells its products through its independent associates who occupy positions in our network and distribute products through similar distribution channels in each country. No single independent associate has ever accounted for more than 10% of the Company’s consolidated net sales. The Company also operates a non-direct selling business in mainland China. Our subsidiary in China, Meitai, is operating as a traditional retailer under a cross-border e-commerce model. Meitai cannot legally conduct a direct selling business in China unless it acquires a direct selling license in China.

The Company has operations in twelve countries and sells product in twenty-five countries around the world. These operations are located in the United States, Canada, Australia, the Netherlands, the United Kingdom, Japan, the Republic of Korea (South Korea), Taiwan, South Africa, Mexico, Hong Kong and China. We currently sell our products in three regions: (i) the Americas (the United States, Canada and Mexico); (ii) EMEA (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom); and (iii) Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong and China). We also ship our products to customers in the following countries: Belgium, France, Greece, Italy, Luxembourg, and Poland.

Consolidated net sales shipped to customers in these regions, along with pack or associate fee and product information for the three and six months ended June 30, were as follows (in millions, except percentages):
 Three Months Ended
June 30,
Six Months Ended
June 30,
Region2022202120222021
Americas$9.2 26.3 %$12.4 29.2 %$19.5 28.9 %$23.3 28.8 %
Asia/Pacific